AEON Biopharma, Inc. (AMEX:AEON) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of underwritten public offering with milestone warrants Closed: US$15.3M raised · US$0.3221 a share · one two-year milestone warrant (exercise price $0.3221) and one five-year milestone… · Lake Street Capital Markets, LLC +1 Dealers: Lake Street Capital Markets, LLC (lead), Laidlaw & Company (UK) Ltd. Use of proceeds: Cash runway into the first quarter of 2027, supporting advancement of the ABP-450 development program | Aug 12, 2026 |
| Private placement of pIPE financing Tranche closed: US$1.79M raised Use of proceeds: Uninterrupted execution of the analytical program and acceleration of ABP-450 biosimilar development | Jan 21, 2026 |